Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3046441016 | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3046754012 | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterized by extensive necrosis and detachment of the epidermis. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3046331018 | Stevens Johnson syndrome AND toxic epidermal necrolysis overlap | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3046358013 | Stevens Johnson syndrome AND toxic epidermal necrolysis overlap (disorder) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | Stevens-Johnson syndrome is a limited form of toxic epidermal necrolysis with characteristics of destruction and detachment of the skin epithelium and mucous membranes involving less than 10% of the body surface area. The disease can be triggered by a drug allergy and, more rarely, by infections or bone marrow transplantation. In 25 to 30% of cases, the cause is unclear. | false | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Oral mucous membrane structure | false | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Due to | A pathological immune process generally directed towards a foreign antigen, which results in tissue injury, which is usually transient. It is the realization of the allergic disposition. It is most often applied to type I hypersensitivity but other hypersensitivity types especially type IV (e.g. allergic contact dermatitis) may be involved. | false | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Erythema | false | Inferred relationship | Some | 3 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | false | Inferred relationship | Some | 3 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | Lyell's toxic epidermal necrolysis, subepidermal type | false | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 1 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 2 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Morbilliform rash (morphologic abnormality) | false | Inferred relationship | Some | 4 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Exfoliative erythema | false | Inferred relationship | Some | 4 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | false | Inferred relationship | Some | 4 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | false | Inferred relationship | Some | 5 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Necrosis | true | Inferred relationship | Some | 2 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Epidermis structure | true | Inferred relationship | Some | 2 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | true | Inferred relationship | Some | 1 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Ulcerative inflammation | false | Inferred relationship | Some | 5 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Oral mucous membrane structure | false | Inferred relationship | Some | 5 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Erythema | true | Inferred relationship | Some | 1 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Clinical course | Sudden onset AND/OR short duration (qualifier value) | true | Inferred relationship | Some | 4 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | The disposition to develop an allergic or pseudoallergic reaction, the reaction itself or its consequences. | true | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Structure of skin and/or mucous membrane (body structure) | true | Inferred relationship | Some | 3 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Separation | true | Inferred relationship | Some | 3 | |
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | A rare toxic dermatosis with clinical and histological features characterized by the destruction and detachment of the skin epithelium and mucous membranes. | true | Inferred relationship | Some | ||
| Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Stevens-Johnson and toxic epidermal necrolysis overlap syndrome caused by drug (disorder) | Is a | True | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Inferred relationship | Some |
This concept is not in any reference sets
FHIR